CTI BioPharma
CTIC
#5841
Rank
NZ$2.18 B
Marketcap
NZ$16.54
Share price
0.00%
Change (1 day)
33.59%
Change (1 year)

EPS for CTI BioPharma (CTIC)

EPS in 2023 (TTM): NZ-$0.95

According to CTI BioPharma 's latest financial reports the company's current EPS (TTM) is NZ-$1.06. In 2022 the company made an earnings per share (EPS) of NZ-$1.55 an increase over its 2021 EPS that were of NZ-$1.96.

EPS history for CTI BioPharma from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$0.95-38.74%
2022NZ-$1.55-21.3%
2021NZ-$1.9645.95%
2020NZ-$1.357.25%
2019NZ-$1.2630.19%
2018NZ-$0.96-58.91%
2017NZ-$2.35-29.12%
2016NZ-$3.31-72.84%
2015NZ-$12.196.35%
2014NZ-$11.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.55-1,005.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$56.20-5,426.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.62-3,096.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$2.57 143.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$3.82-462.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.22-879.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$0.82-177.59%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel